GEN Exclusives

More »

GEN News Highlights

More »
Dec 5, 2006

Cepheid Receives $14M CDC Contract for Avian Influenza Test

  • Cepheid received a contract from the CDC for up to $14.9 million to develop a rapid point-of-care diagnostic to detect influenza viruses A and B and the H5N1 avian influenza virus in human respiratory specimens.

    The objective of the program is to develop a rapid, highly accurate patient test utilizing real-time PCR on a broadly disseminated basis in virtually any setting. Cepheid will develop a fully automated, self-contained test that does not require the user to have technical or specialized training on its GeneXpert system.

    An initial allocation of $2.4 million for Phases I and II of the five-phase program was made in December. The proposed test will be developed over a 30-month period as part of a government program directed at pandemic preparedness.


GEN Jobs powered by connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
More »

Be sure to take the GEN Poll

Patient Access to Genetic Information

Do you think patients have the absolute right to gain access to their own genetic information from medical or clinical laboratories?

More »